These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2618548)

  • 21. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of NK cell activity and proliferation in cultured lymphocytes of leukemic patients by monoclonal antibodies CD3 and interleukin-2.
    Soucek J; Hilgert I; Budová I; Lindnerová G
    Neoplasma; 1994; 41(2):75-81. PubMed ID: 8208318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of anti-HTLV antibody titer, abnormal lymphocytes in HTLV carriers and HTLV genome negative adult T-cell leukemia-lymphoma.
    Shimoyama M; Seki S; Nagai M; Minato K; Kitamura T; Hoshino H; Miwa M; Tobinai K; Nagoshi H; Oosuga T
    Princess Takamatsu Symp; 1984; 15():71-6. PubMed ID: 6152761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells.
    Lo KM; Vivier E; Rochet N; Dehni G; Levine H; Haseltine WA; Anderson P
    J Immunol; 1992 Dec; 149(12):4101-8. PubMed ID: 1460293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
    Niwa R; Sakurada M; Kobayashi Y; Uehara A; Matsushima K; Ueda R; Nakamura K; Shitara K
    Clin Cancer Res; 2005 Mar; 11(6):2327-36. PubMed ID: 15788684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibody-dependent cellular cytotoxicity (AAZZ) against leukemia cells--K-cell activity of human leukocytes].
    Thränhardt H; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):824-40. PubMed ID: 6162750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
    Santoni A; Herberman RB; Holden HT
    J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations.
    de Landazuri MO; Silva A; Alvarez J; Herberman RB
    J Immunol; 1979 Jul; 123(1):252-8. PubMed ID: 376742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of antibody-dependent cellular cytotoxicity against endothelial cells by renal transplantation.
    Miltenburg AM; Meijer-Paape ME; Weening JJ; Daha MR; van Es LA; van der Woude FJ
    Transplantation; 1989 Oct; 48(4):681-8. PubMed ID: 2799923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia.
    Tanaka H; Fujiwara H; Ochi F; Tanimoto K; Casey N; Okamoto S; Mineno J; Kuzushima K; Shiku H; Sugiyama T; Barrett AJ; Yasukawa M
    Clin Cancer Res; 2016 Sep; 22(17):4405-16. PubMed ID: 27091408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity.
    Kramski M; Schorcht A; Johnston AP; Lichtfuss GF; Jegaskanda S; De Rose R; Stratov I; Kelleher AD; French MA; Center RJ; Jaworowski A; Kent SJ
    J Immunol Methods; 2012 Oct; 384(1-2):51-61. PubMed ID: 22841577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The possible mode of escape of adult T-cell leukaemia cells from antibody-dependent cellular cytotoxicity.
    Kozuru M; Uike N; Takeichi N; Nakagawa S; Takahira H; Shibata K; Sato H
    Br J Haematol; 1989 Aug; 72(4):502-6. PubMed ID: 2624625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice.
    Stewart SA; Feuer G; Jewett A; Lee FV; Bonavida B; Chen IS
    Virology; 1996 Dec; 226(2):167-75. PubMed ID: 8955035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cell activity and serum autoantibodies in women with postpartum thyroiditis.
    Hayslip CC; Baker JR; Wartofsky L; Klein TA; Opsahl MS; Burman KD
    J Clin Endocrinol Metab; 1988 May; 66(5):1089-93. PubMed ID: 3360899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-2-dependent HTLV-I-infected T cells escape from non-specific, MHC-unrestricted cellular cytotoxicity.
    Plotnicky H; Cyblat D; Vernant JC; Desgranges C
    Clin Immunol Immunopathol; 1994 Nov; 73(2):205-14. PubMed ID: 7923927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.